Trademark: CTX001
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for CTX001
We do not have any records of a proof of use for CTX001 at this moment.
Possible trademark infringements of CTX001
Basic Information about CTX001
- Serial Number
- 97267617
- Filing Date
- 15 Feb 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of CTX001 on the blockchain with WikiTrademarks.io.
- First use of CTX001 anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
- First use of CTX001 anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
- First use of CTX001 anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns CTX001?
1. Vertex Pharmaceuticals Incorporated Boston MA
Correspondent
- Timothy H. Hiebert
- WOMBLE BOND DICKINSON (US) LLP
- 470 ATLANTIC AVE.
- BOSTON MA 02210-2228
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io